Symptoms: Aromatase inhibitor induced arthralgias

Advances in Experimental Medicine and Biology

Volumn 862, Issue , 2015, Pages 89-100

  Hershman, Dawn L ^a   Loprinzi, Charles ^b   Schneider, Bryan P ^c  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b Regis Professor of Breast Cancer Research Division of Medical Oncology   (United States)

^c INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Aromatase inhibitors; Arthralgias; Breast cancer

Indexed keywords

AROMATASE INHIBITOR; CHONDROITIN; COLECALCIFEROL; DULOXETINE; GLUCOSAMINE; NONSTEROID ANTIINFLAMMATORY AGENT; OMEGA 3 FATTY ACID; PLACEBO; PREDNISOLONE; TESTOSTERONE;

ACUPUNCTURE; ARTHRALGIA; ARTICLE; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; EXERCISE; HUMAN; OUTCOME ASSESSMENT; PATHOGENESIS; PHASE 2 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK ASSESSMENT; RISK FACTOR; SYMPTOM; VITAMIN SUPPLEMENTATION; BREAST NEOPLASMS; CHEMICALLY INDUCED; COMPLICATION; FEMALE; VITAMIN D DEFICIENCY;

ACUPUNCTURE THERAPY; AROMATASE INHIBITORS; ARTHRALGIA; BREAST NEOPLASMS; CHONDROITIN; FEMALE; GLUCOSAMINE; HUMANS; RISK FACTORS; VITAMIN D DEFICIENCY;

EID: 84931266021     PISSN: 00652598     EISSN: 22148019     Source Type: Book Series    
DOI: 10.1007/978-3-319-16366-6_7     Document Type: Article

References (57)

1. Anonymous (1998) NIH consensus conference. Acupuncture. JAMA 280:1518–1524
2. Azria D, Lamy Y, Belkacemi G et al (2007) Letrozole-induced arthralgia: results of a multicenteric prospective trial exploring clinical parameters and plasma biomarkers. ASCO Breast Cancer Symposium
3. Baum M, Budzar AU, Cuzick J (2002) Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: fi rst results of the ATAC randomised trial. Lancet 359:2131–2139 [see comment][erratum appears in Lancet 2002 Nov 9;360(9344):1520]
4. Birrell S, Tilley W (2009) Testosterone undecanoate treatment reduces joint morbidities induced by anastrozole therapy in postmenopausal women with breast cancer: results of a double-blind, randomized phase II trial. San Antonio breast cancer symposium
5. Blanchard O, Tsagris L, Rappaport R et al (1991) Age-dependent responsiveness of rabbit and human cartilage cells to sex steroids in vitro. J Steroid Biochem Mol Biol 40:711–716
6. Briot K, Tubiana-Hulin M, Bastit L et al (2010) Effect of a switch of aromatase inhibitors on mus-culoskeletal symptoms in postmenopausal women with hormone-receptor-positive breast cancer: the ATOLL (articular tolerance of letrozole) study. Breast Cancer Res Treat 120:127–134
7. Carey TS, Evans A, Hadler N et al (1995) Care-seeking among individuals with chronic low back pain. Spine 20:312–317
8. Chlebowski RT, Cirillo DJ, Eaton CB et al (2013) Estrogen alone and joint symptoms in the women’s health initiative randomized trial. Menopause 20:600–608
9. Claassen H, Schluter M, Schunke M et al (2006) Infl uence of 17beta-estradiol and insulin on type II collagen and protein synthesis of articular chondrocytes. Bone 39:310–317
10. Coombes RC, Hall E, Gibson LJ et al (2004) A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer. N Engl J Med 350:1081–1092
11. Crew KD, Greenlee H, Capodice J et al (2007) Prevalence of joint symptoms in postmenopausal women taking aromatase inhibitors for early-stage breast cancer. J Clin Oncol 25:3877–3883
12. Crew KD, Capodice J, Greenlee H et al (2010) Randomized, blinded, sham-controlled trial of acupuncture for the management of aromatase inhibitor-associated joint symptoms in women with early stage breast cancer. J Clin Oncol 28:1154–1160
13. Cuzick J, Sestak I, Cella D et al (2008) Treatment-emergent endocrine symptoms and the risk of breast cancer recurrence: a retrospective analysis of the ATAC trial. Lancet Oncol 9:1143–1148
14. Dayani N, Corvol MT, Robel P et al (1988) Estrogen receptors in cultured rabbit articular chondro-cytes: infl uence of age. J Steroid Biochem 31:351–356
15. DeSantis C, Ma J, Bryan L et al (2014) Breast cancer statistics, 2013. CA Cancer J Clin 64:52–62
16. Dizdar O, Ozcakar L, Malas FU et al (2009) Sonographic and electrodiagnostic evaluations in patients with aromatase inhibitor-related arthralgia. J Clin Oncol 27:4955–4960
17. Dougherty RH, Rohrer JL, Hayden D et al (2005) Effect of aromatase inhibition on lipids and infl ammatory markers of cardiovascular disease in elderly men with low testosterone levels. Clin Endocrinol (Oxf) 62:228–235
18. Galantino ML, Callens ML, Cardena GJ et al (2013) Tai chi for well-being of breast cancer survivors with aromatase inhibitor-associated arthralgias: a feasibility study. Altern Ther Health Med 19:38–44
19. Garcia-Giralt N, Rodriguez-Sanz M, Prieto-Alhambra D et al (2013) Genetic determinants of aro-matase inhibitor-related arthralgia: the B-ABLE cohort study. Breast Cancer Res Treat 140:385–395
20. Goss PE, Ingle JN, Martino S et al (2003) A randomized trial of letrozole in postmenopausal women after fi ve years of tamoxifen therapy for early-stage breast cancer. N Engl J Med 349:1793–1802 [see comment]
21. Goss PE, Ingle JN, Martino S et al (2005) Randomized trial of letrozole following tamoxifen as extended adjuvant therapy in receptor-positive breast cancer: updated fi ndings from NCIC CTG MA.17. J Natl Cancer Inst 97:1262–1271
22. Greenlee H, Crew KD, Shao T et al (2013) Phase II study of glucosamine with chondroitin on aromatase inhibitor-associated joint symptoms in women with breast cancer. Support Care Cancer 21:1077–1087
23. Guerne PA, Carson DA, Lotz M (1990) IL-6 production by human articular chondrocytes. Modulation of its synthesis by cytokines, growth factors, and hormones in vitro. J Immunol 144:499–505
24. Hadji P, Kieback DG, Tams J et al (2012) Correlation of treatment-emergent adverse events and clinical response to endocrine therapy in early breast cancer: a retrospective analysis of the German cohort of TEAM. Ann Oncol 23:2566–2572
25. Hadji P, Jackisch C, Bolten W et al (2014) COMPliance and arthralgia in clinical therapy: the COMPACT trial, assessing the incidence of arthralgia, and compliance within the fi rst year of adjuvant anastrozole therapy. Ann Oncol 25:372–377
26. Harputluoglu H, Dizdar O, Malas U et al (2008) Aromatase inhibitor-associated arthralgia: prevalence, clinical and serum parameters among Turkish postmenopausal breast cancer patients. ASCO Annual Meeting. J Clin Oncol (May 20 supplement)
27. Henry NL, Giles JT, Ang D et al (2008) Prospective characterization of musculoskeletal symptoms in early stage breast cancer patients treated with aromatase inhibitors. Breast Cancer Res Treat 111:365–372
28. Henry NL, Banerjee M, Wicha M et al (2011) Pilot study of duloxetine for treatment of aromatase inhibitor-associated musculoskeletal symptoms. Cancer 117:5469–5475
29. Henry NL, Azzouz F, Desta Z et al (2012) Predictors of aromatase inhibitor discontinuation as a result of treatment-emergent symptoms in early-stage breast cancer. J Clin Oncol 30:936–942
30. Henry NL, Conlon A, Kidwell KM et al (2014) Effect of estrogen depletion on pain sensitivity in aromatase inhibitor-treated women with early-stage breast cancer. J Pain 15:468–475
31. Hershman D, Unger J, Crew K et al (2014) Omega-3 fatty acids for aromatase inhibitor–induced musculoskeletal symptoms in women with early-stage breast cancer (SWOG S0927)
32. Howell A, Cuzick J, Baum M et al (2005) Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years’ adjuvant treatment for breast cancer. Lancet 365:60–62
33. Irwin M, Cartmel B, Gross C et al (2013) Effect of exercise vs. usual care on aromatase inhibitor-associated arthralgias in women with early stage breast cancer: the hormones and physical exercise (HOPE) Study. SABCS
34. Kewman DG, Vaishampayan N, Zald D et al (1991) Cognitive impairment in musculoskeletal pain patients. Int J Psychiatry Med 21:253–262
35. Khan QJ, Reddy PS, Kimler BF et al (2010) Effect of vitamin D supplementation on serum 25-hydroxy vitamin D levels, joint pain, and fatigue in women starting adjuvant letrozole treatment for breast cancer. Breast Cancer Res Treat 119(1):111–118
36. Khan Q, Kimler B, Reddy P et al (2012) Randomized trial of vitamin D3 to prevent worsening of musculoskeletal symptoms and fatigue in women with breast cancer starting adjuvant letro-zole: the VITAL trial. J Clin Oncol 30(suppl; abstr 9000)
37. Kubo M, Onishi H, Kuroki S et al (2012) Short-term and low-dose prednisolone administration reduces aromatase inhibitor-induced arthralgia in patients with breast cancer. Anticancer Res 32:2331–2336
38. Laroche M, Borg S, Lassoued S et al (2007) Joint pain with aromatase inhibitors: abnormal frequency of Sjogren’s syndrome. J Rheumatol 34:2259–2263
39. Laroche F, Coste J, Medkour T et al (2014) Classifi cation of and risk factors for estrogen deprivation pain syndromes related to aromatase inhibitor treatments in women with breast cancer: a prospective multicenter cohort study. J Pain 15:293–303
40. Lintermans A, Van Calster B, Van Hoydonck M et al (2011) Aromatase inhibitor-induced loss of grip strength is body mass index dependent: hypothesis-generating fi ndings for its pathogene-sis. Ann Oncol 22:1763–1769
41. Mao JJ, Su HI, Feng R et al (2011) Association of functional polymorphisms in CYP19A1 with aromatase inhibitor associated arthralgia in breast cancer survivors. Breast Cancer Res 13:R8
42. Mao JJ, Xie SX, Farrar JT et al (2014) A randomised trial of electro-acupuncture for arthralgia related to aromatase inhibitor use. Eur J Cancer 50:267–276
43. Mieog JS, Morden JP, Bliss JM et al (2012) Carpal tunnel syndrome and musculoskeletal symptoms in postmenopausal women with early breast cancer treated with exemestane or tamoxifen after 2-3 years of tamoxifen: a retrospective analysis of the intergroup exemestane study. Lancet Oncol 13:420–432
44. Morales L, Pans S, Verschueren K et al (2008) Prospective study to assess short-term intra- articular and tenosynovial changes in the aromatase inhibitor-associated arthralgia syndrome. J Clin Oncol 26:3147–3152
45. Niravath P (2013) Aromatase inhibitor-induced arthralgia: a review. Ann Oncol 24:1443–1449
46. Oh B, Kimble B, Costa DS et al (2013) Acupuncture for treatment of arthralgia secondary to aro-matase inhibitor therapy in women with early breast cancer: pilot study. Acupunct Med 31:264–271
47. Richette P, Corvol M, Bardin T (2003) Estrogens, cartilage, and osteoarthritis. Joint Bone Spine 70:257–262
48. Richmond RS, Carlson CS, Register TC et al (2000) Functional estrogen receptors in adult articular cartilage: estrogen replacement therapy increases chondrocyte synthesis of proteoglycans and insulin-like growth factor binding protein 2. Arthritis Rheum 43:2081–2090
49. Riggs BL, Melton LJ 3rd (1992) The prevention and treatment of osteoporosis. N Engl J Med 327:620–627 [see comment][erratum appears in N Engl J Med. 1993 Jan 7;328(1):65; author reply 66; PMID: 8416278]
50. Rosner IA, Manni A, Malemud CJ et al (1982) Estradiol receptors in articular chondrocytes. Biochem Biophys Res Commun 106:1378–1382
51. Scudds RJ, Mc DRJ (1998) Empirical evidence of the association between the presence of muscu-loskeletal pain and physical disability in community-dwelling senior citizens. Pain 75:229–235
52. Sestak I, Cuzick J, Sapunar F et al (2008) Risk factors for joint symptoms in patients enrolled in the ATAC trial: a retrospective, exploratory analysis. Lancet Oncol 9:866–872
53. Sestak I, Sapunar F, Cuzick J (2009) Aromatase inhibitor-induced carpal tunnel syndrome: results from the ATAC trial. J Clin Oncol 27:4961–4965
54. Sherwin BB (1996) Hormones, mood, and cognitive functioning in postmenopausal women. Obstet Gynecol 87
55. Shi Q, Giordano SH, Lu H et al (2013) Anastrozole-associated joint pain and other symptoms in patients with breast cancer. J Pain 14:290–296
56. Thurlimann B, Keshaviah A, Coates AS et al (2005) A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer. N Engl J Med 353:2747–2757
57. Ushiyama T, Inoue K, Nishioka J (1995) Expression of estrogen receptor related protein (p29) and estradiol binding in human arthritic synovium. J Rheumatol 22:421–426